Cargando…
Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
We have now at our disposal the new rapid-acting insulin analogs, of which insulin lispro was the first to become commercially available. While the differences in pharmacokinetic and pharmacodynamic characteristics are indisputable, the clinical benefits attained by these changes have not been as cl...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267520/ https://www.ncbi.nlm.nih.gov/pubmed/22291471 http://dx.doi.org/10.2147/DMSO.S15404 |